{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T01:33:58Z","timestamp":1715996038657},"reference-count":50,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T00:00:00Z","timestamp":1171843200000},"content-version":"vor","delay-in-days":963,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Geri Cardiology"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:p> <jats:bold>\n            <jats:italic>Older patients with hypertension are often inadequately treated due to misconceptions regarding reasonable goal blood pressures or concerns about treatment side effects. Adequately treating hypertension can yield impressive benefits in terms of improved morbidity and enhanced quality of life in persons of any age. Antagonists of the renin\u2010angiotensin\u2010aldosterone system are especially effective in older persons, many of whom have concomitant conditions such as diabetes mellitus, renal dysfunction, and other cardiovascular risk factors. Treatment with angiotensin\u2010converting enzyme inhibitors and angiotensin II receptor blockers has been shown to improve many of the complications of hypertension, including left ventricular hypertrophy and renal disease. Results of recent key studies such as Losartan Intervention For Endpoint Reduction in Hypertension (LIFE), Valsartan in Heart Failure Trial (Val\u2010HeFT), Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM), and Valsartan in Acute Myocardial Infarction (VALIANT) add to the evidence that angiotensin II receptor blockers are well suited for the treatment of hypertension in older patients. These trials also indicate that they are appropriate therapy for heart failure patients and for patients who have experienced acute myocardial infarction, particularly those who are unable to tolerate an angiotensin\u2010converting enzyme inhibitor.<\/jats:italic>\n          <\/jats:bold> <\/jats:p>","DOI":"10.1111\/j.1076-7460.2004.03701.x","type":"journal-article","created":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T16:21:28Z","timestamp":1171902088000},"page":"197-205","source":"Crossref","is-referenced-by-count":7,"title":["Angiotensin II Receptor Blockers in Older Patients"],"prefix":"10.1111","volume":"13","author":[{"given":"Michael A.","family":"Weber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,2,19]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.23.3.275"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(91)90694-D"},{"key":"e_1_2_10_4_2","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","article-title":"Joint National Committee. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.19.2560"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000031805.09178.37"},{"issue":"2","key":"e_1_2_10_7_2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/080370501750275866","article-title":"Parving H\u2010H. Hypertension and diabetes: the scope of the problem","volume":"10","year":"2001","journal-title":"Blood Press"},{"key":"e_1_2_10_8_2","unstructured":"Heart Disease and Stroke Statistics 2003 Update 2002"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530440037034"},{"key":"e_1_2_10_10_2","author":"Hunt SA","journal-title":"ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure)"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.120773"},{"issue":"1","key":"e_1_2_10_12_2","first-page":"S94","article-title":"American Diabetes Association. Diabetic nephropathy","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1076-7460.2001.00019.x"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00105-3"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00262-6"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1999.1547"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.6.904"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1076-7460.2001.90855.x"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960240303"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.19.2037"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08089-3"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-3-200308050-00006"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000083724.28630.C3"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)01187-2"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010713"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02213-3"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02304-5"},{"key":"e_1_2_10_28_2","unstructured":"Diovan [package insert] 2002"},{"key":"e_1_2_10_29_2","first-page":"II\u2010685","article-title":"Efficacy of valsartan in elderly heart failure patients in Val\u2010HeFT [abstract]","volume":"106","author":"Baruch L","year":"2002","journal-title":"Circulation"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1071-9164(99)90013-1"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14282-1"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14283-3"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14284-5"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14285-7"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.102904"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)10327-1"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200018110-00020"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09895-1"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(03)00168-6"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032292"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-9842(03)00112-0"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)12323-7"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011161"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011303"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000024416.33113.0A"},{"key":"e_1_2_10_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/153.1.72"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03086-4"},{"key":"e_1_2_10_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200305000-00011"},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001613"},{"key":"e_1_2_10_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2002.00749.x"},{"issue":"1","key":"e_1_2_10_51_2","first-page":"S3","article-title":"Current recommendations for the treatment of hypertension: are they still valid","volume":"20","author":"Moser M","year":"2002","journal-title":"J Hypertens"}],"container-title":["The American Journal of Geriatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1076-7460.2004.03701.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1076-7460.2004.03701.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T01:57:23Z","timestamp":1694397443000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1076-7460.2004.03701.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1111\/j.1076-7460.2004.03701.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1076-7460.2004.03701.x","archive":["Portico"],"relation":{},"ISSN":["1076-7460","1751-715X"],"issn-type":[{"value":"1076-7460","type":"print"},{"value":"1751-715X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}